Invasive Escherichia coli are a feature of Crohn's disease.
Crohn's disease (CD) and ulcerative colitis (UC) are idiopathic inflammatory conditions of the gut. Our goal was to investigate if invasive Escherichia coli strains were present in patients with inflammatory bowel disease (IBD). Bacterial strains were isolated from biopsy material obtained from normal controls, and patients with a clinical diagnosis of CD and UC. Invasive bacteria were characterized by gentamicin protection assay and biochemical profiling (Api-20E). Strains were characterized by induction of cytokine expression in epithelial and macrophage cell cultures, measurement of epithelial barrier function, and confocal microscopy. Of all invasive bacterial strains in CD 98.9% were identified as E. coli as opposed to 42.1% in UC and 2.1% in normal controls. Epithelial invasion in vitro was significantly higher for CD-associated E. coli (8.4%, +/-5.5 of initial inoculum (I/O)) in comparison to UC (2.5%, +/-0.4 I/O), but highest for strains from inflamed CD tissue (11.3%, +/-4.3 I/O). Both, CD and UC E. coli strains induced high mean TNF-alpha expression in macrophage cell lines (2604.8 pg/10(5) cells, +/-447.4; 2,402.6 pg/10(5) cells, +/-476.3, respectively), but concentrations were significantly higher for isolates from inflamed CD tissue (3071.3 pg/10(5) cells, +/-226.0). Invasive E. coli from IBD tissue induced similar concentrations of interleukin (IL)-8 in epithelial cell cultures, but strains from inflamed CD tissue induced significantly less epithelial IL-8 (674.1 pg/10(5) cells, +/-58.0 vs 920.5 pg/10(5) cells, +/-94.6). IBD-associated E. coli strains significantly decreased transepithelial resistance, induced disorganization of F-actin and displacement of ZO-1, and E-cadherin from the apical junctional complex (AJC). In comparison to normal controls and UC, E. coli are more prevalent in CD, are highly invasive, and do not encode for known effector proteins. E. coli strains from IBD patients regulate cytokine expression and epithelial barrier function, two pathological features of IBD.
Sasaki
Maiko
M
Internal Medicine, Division of Digestive Diseases, Emory University, Atlanta, GA 30322, USA.
Sitaraman
Shanti V
SV
Babbin
Brian A
BA
Gerner-Smidt
Peter
P
Ribot
Efrain M
EM
Garrett
Nancy
N
Alpern
Joel A
JA
Akyildiz
Adil
A
Theiss
Arianne L
AL
Nusrat
Asma
A
Klapproth
Jan-Michael A
JM
D018938:Caco-2 Cells; D016022:Case-Control Studies; D003093:Colitis, Ulcerative / Q000378:metabolism / Q000382:microbiology*; D003424:Crohn Disease / Q000378:metabolism / Q000382:microbiology*; D016207:Cytokines / Q000378:metabolism*; D004926:Escherichia coli / Q000235:genetics / Q000472:pathogenicity*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism / Q000382:microbiology*; D010539:Permeability
D016207:Cytokines